Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1247873.RA1rw35OnCtN0TixTC_3DkJISfVXehb9NMMagcrqHegKw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1247873.RA1rw35OnCtN0TixTC_3DkJISfVXehb9NMMagcrqHegKw130_assertion type Assertion NP1247873.RA1rw35OnCtN0TixTC_3DkJISfVXehb9NMMagcrqHegKw130_head.
- NP1247873.RA1rw35OnCtN0TixTC_3DkJISfVXehb9NMMagcrqHegKw130_assertion description "[Between October 2009 and June 2013, 56 patients with advanced NSCLC were analyzed for EGFR somatic mutations and treated with S-1 with or without bevacizumab.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247873.RA1rw35OnCtN0TixTC_3DkJISfVXehb9NMMagcrqHegKw130_provenance.
- NP1247873.RA1rw35OnCtN0TixTC_3DkJISfVXehb9NMMagcrqHegKw130_assertion evidence source_evidence_literature NP1247873.RA1rw35OnCtN0TixTC_3DkJISfVXehb9NMMagcrqHegKw130_provenance.
- NP1247873.RA1rw35OnCtN0TixTC_3DkJISfVXehb9NMMagcrqHegKw130_assertion SIO_000772 25503189 NP1247873.RA1rw35OnCtN0TixTC_3DkJISfVXehb9NMMagcrqHegKw130_provenance.
- NP1247873.RA1rw35OnCtN0TixTC_3DkJISfVXehb9NMMagcrqHegKw130_assertion wasDerivedFrom befree-2016 NP1247873.RA1rw35OnCtN0TixTC_3DkJISfVXehb9NMMagcrqHegKw130_provenance.
- NP1247873.RA1rw35OnCtN0TixTC_3DkJISfVXehb9NMMagcrqHegKw130_assertion wasGeneratedBy ECO_0000203 NP1247873.RA1rw35OnCtN0TixTC_3DkJISfVXehb9NMMagcrqHegKw130_provenance.